Gorlin
Gorlin syndrome, also known as nevoid basal cell carcinoma syndrome (NBCCS) or Gorlin-Goltz syndrome, is a rare genetic disorder that predisposes individuals to various developmental abnormalities and an increased risk of developing certain types of cancer, particularly basal cell carcinoma. The syndrome is named after Dr. Robert J. Gorlin, who first described it in 1960.
Genetics[edit | edit source]
Gorlin syndrome is typically inherited in an autosomal dominant pattern, meaning that a single copy of the altered gene in each cell is sufficient to cause the disorder. The condition is most commonly associated with mutations in the PTCH1 gene, which is a part of the Hedgehog signaling pathway. Mutations in the SUFU gene have also been implicated in some cases.
Clinical Features[edit | edit source]
Individuals with Gorlin syndrome may exhibit a wide range of symptoms, including:
- Multiple basal cell carcinomas at a young age
- Keratocystic odontogenic tumors (jaw cysts)
- Palmar and plantar pits
- Skeletal abnormalities such as bifid ribs and scoliosis
- Calcification of the falx cerebri
- Medulloblastoma (a type of brain tumor) in children
Diagnosis[edit | edit source]
Diagnosis of Gorlin syndrome is based on clinical criteria and genetic testing. Major criteria include the presence of multiple basal cell carcinomas, jaw cysts, and palmar or plantar pits. Genetic testing can confirm mutations in the PTCH1 or SUFU genes.
Management[edit | edit source]
Management of Gorlin syndrome involves regular monitoring for the development of basal cell carcinomas and other associated tumors. Treatment may include surgical removal of tumors, radiation therapy, and the use of hedgehog pathway inhibitors such as vismodegib.
Prognosis[edit | edit source]
The prognosis for individuals with Gorlin syndrome varies depending on the severity of symptoms and the effectiveness of treatment. Early detection and management of basal cell carcinomas and other tumors are crucial for improving outcomes.
Related Pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD